GlassScriptPhysician profile
Angela L Cartwright
NPI 1548252000
$1,514.68
in general payments reported to CMS, 2019-2025
27 companies · $154 in 2025
The $154 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $492 · 2020: $126 · 2021: $332 · 2022: $125 · 2023: $152 · 2024: $133 · 2025: $154.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $439.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $438.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $186.25 | 2019-2022 | |
| Astellas Pharma US INC | $150.83 | 2019-2025 | Veozah |
| Abbvie INC. | $144.88 | 2019-2022 | |
| Mayne Pharma Commercial LLC | $91.69 | 2021-2025 | |
| Pfizer INC. | $85.48 | 2019-2024 | |
| Mylan Pharmaceuticals INC. | $75.89 | 2021-2022 | |
| Agile Therapeutics, INC. | $73.72 | 2021-2022 | |
| Amgen INC. | $72.51 | 2019-2021 | |
| Exeltis, USA INC. | $70.08 | 2019-2023 | Slynd |
| Merck Sharp & Dohme LLC | $68.92 | 2019 | |
| Roche Diagnostics Corporation | $64.44 | 2019-2021 | |
| Sumitomo Pharma America, INC. | $59.15 | 2024-2025 | Myfembree |
| Lupin INC. | $56.41 | 2019-2021 | |
| Optumhealth Care Solutions, LLC | $46.15 | 2024-2025 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Hologic Sales and Service, LLC | $39.22 | 2023-2024 | Third Wave, Thinprep 2000 Processor, Aptima |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Evofem Biosciences, INC. | $33.28 | 2021 | |
| Exact Sciences Corporation | $24.38 | 2025 | Cologuard Collection Kit |
| Amag Pharmaceuticals, INC. | $22.04 | 2019 | |
| Organon LLC | $21.89 | 2021 | |
| Myovant Sciences INC. | $18.25 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $17.93 | 2022 | |
| Millicent US INC | $17.81 | 2025 | Femlyv |
| Duchesnay USA Incorporated | $16.79 | 2019 | |
| Virtus Pharmaceuticals LLC | $15.93 | 2021 | |
| Coopersurgical, INC. | $14.58 | 2024 | Endosee |
| Cumberland Pharmaceuticals, INC. | $13.71 | 2024 | Caldolor |
| Vertical Pharmaceuticals, LLC | $12.47 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angela Cartwright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.